Berberine reduces methylation of the MTTP promoter and alleviates fatty liver induced by a high-fat diet in rats

Journal of Lipid Research

Volumn 51, Issue 9, 2010, Pages 2504-2515

  Chang, XinXia ^a   Yan, HongMei ^a   Fei, Jing ^b   Jiang, MingHong ^b   Zhu, HongGuang ^a   Lu, DaRu ^b   Gao, Xin ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY   (China)

Author keywords

DNA methylation; Microsomal triglyceride transfer protein; Nonalcoholic fatty liver disease

Indexed keywords

ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE 1; BERBERINE; CARNITINE PALMITOYLTRANSFERASE I; CARNITINE PALMITOYLTRANSFERASE IALPHA; DIACYLGLYCEROL ACYLTRANSFERASE 1; DIACYLGLYCEROL ACYLTRANSFERASE 2; DNA METHYLTRANSFERASE; GLUCOSE; HOMOCYSTEINE; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR; MESSENGER RNA; MICROSOMAL TRIGLYCERIDE TRANSFER PROTEIN; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; UNCOUPLING PROTEIN 2; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DEMETHYLATION; DNA METHYLATION; DOWN REGULATION; DRUG ACTIVITY; FATTY ACID OXIDATION; GENE EXPRESSION; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAABDOMINAL FAT; LIPID DIET; LIPID METABOLISM; LIVER CELL; MALE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROMOTER REGION; RAT; SPRAGUE DAWLEY RAT; TREATMENT DURATION;

AMINO ACID SEQUENCE; ANIMALS; BASE SEQUENCE; BERBERINE; CARRIER PROTEINS; DIET; DIETARY FATS; DNA METHYLATION; FATTY LIVER; INSULIN RESISTANCE; LIPID METABOLISM; LIPOPROTEINS, VLDL; MALE; MICE; MOLECULAR SEQUENCE DATA; PROMOTER REGIONS, GENETIC; RATS; RATS, INBRED BUF; RATS, SPRAGUE-DAWLEY; SEQUENCE ANALYSIS, DNA; TRIGLYCERIDES;

EID: 77956864571     PISSN: 00222275     EISSN: 15397262     Source Type: Journal    
DOI: 10.1194/jlr.M001958     Document Type: Article

References (41)

1. Kohjima, M., M. Enjoji, N. Higuchi, M. Kato, K. Kotoh, T. Yoshimoto, T. Fujino, M. Yada, R. Yada, N. Harada, et al. 2007. Re-evaluation of fatty acid metabolism-related gene expression in nonalcoholic fatty liver disease. Int. J. Mol. Med. 20: 351-358.
2. Adams, L. A., P. Angulo, and K. D. Lindor. 2005. Nonalcoholic fatty liver disease. CMAJ. 172: 899-905.
3. Leung, D. H., K. Williams, J. K. Fraley, and W. J. Klish. 2009. Age- and ethnic-specific elevation of ALT among obese children at risk for nonalcoholic steatohepatitis (NASH): implications for screening. Clin. Pediatr. (Phila.). 48: 50-57.
4. Hanley, A. J., K. Williams, A. Festa, L. E. Wagenknecht, R. B. D'Agostino, Jr., J. Kempf, B. Zinman, and S. M. Haffner. 2004. Elevations in markers of liver injury and risk of type 2 diabetes: the insulin resistance atherosclerosis study. Diabetes. 53: 2623-2632.
5. Vozarova, B., N. Stefan, R. S. Lindsay, A. Saremi, R. E. Pratley, C. Bogardus, and P. A. Tataranni. 2002. High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes. Diabetes. 51: 1889-1895.
6. Yan, H-M., X. Gao, M. Liu, Q. Gu, B. Zhang, X. Li, J. Gao, and N. Q. Zhao. 2006. Study of the association between non-alcoholic fatty liver disease and metabolic syndrome. Chin. J. Diabetes. 14: 326-328.
7. Samuel, V. T., Z. X. Liu, X. Qu, B. D. Elder, S. Bilz, D. Befroy, A. J. Romanelli, and G. I. Shulman. 2004. Mechanism of hepatic insulin resistance in non-alcoholic fatty liver disease. J. Biol. Chem. 279: 32345-32353.
8. Petersen, K. F., S. Dufour, D. Befroy, M. Lehrke, R. E. Hendler, and G. I. Shulman. 2005. Reversal of nonalcoholic hepatic steatosis, hepatic insulin resistance, and hyperglycemia by moderate weight reduction in patients with type 2 diabetes. Diabetes. 54: 603-608.
9. Schindhelm, R. K., J. M. Dekker, G. Nijpels, L. M. Bouter, C. D. Stehouwer, R. J. Heine, and M. Diamant. 2007. Alanine aminotransferase predicts coronary heart disease events: a 10-year follow-up of the Hoorn Study. Atherosclerosis. 191: 391-396. (Pubitemid 46400701)
10. Postic, C., and J. Girard. 2008. Contribution of de novo fatty acid synthesis to hepatic steatosis and insulin resistance: lessons from genetically engineered mice. J. Clin. Invest. 118: 829-838.
11. Lee, Y. S., W. S. Kim, K. H. Kim, M. J. Yoon, H. J. Cho, Y. Shen, J. M. Ye, C. H. Lee, W. K. Oh, C. T. Kim, et al. 2006. Berberine, a natural plant product, activates AMP-activated protein kinase with beneficial metabolic effects in diabetic and insulin-resistant states. Diabetes. 55: 2256-2264.
12. Kong, W., J. Wei, P. Abidi, M. Lin, S. Inaba, C. Li, Y. Wang, Z. Wang, S. Si, H. Pan, et al. 2004. Berberine is a novel cholesterol-lowering drug working through a unique mechanism distinct from statins. Nat. Med. 10: 1344-1351.
13. Zhang, Y., X. Li, D. Zou, W. Liu, J. Yang, N. Zhu, L. Huo, M. Wang, J. Hong, P. Wu, et al. 2008. Treatment of type 2 diabetes and dyslipidemia with the natural plant alkaloid berberine. J. Clin. Endocrinol. Metab. 93: 2559-2565.
14. Kim, W. S., Y. S. Lee, S. H. Cha, H. W. Jeong, S. S. Choe, M. R. Lee, G. T. Oh, H. S. Park, K. U. Lee, M. D. Lane, et al. 2009. Berberine improves lipid dysregulation in obesity by controlling central and peripheral AMPK activity. Am. J. Physiol. Endocrinol. Metab. 296: E812-E819.
15. Ling, C., P. Poulsen, S. Simonsson, T. Ronn, J. Holmkvist, P. Almgren, P. Hagert, E. Nilsson, A. G. Mabey, P. Nilsson, et al. 2007. Genetic and epigenetic factors are associated with expression of respiratory chain component NDUFB6 in human skeletal muscle. J. Clin. Invest. 117: 3427-3435.
16. Ronn, T., P. Poulsen, O. Hansson, J. Holmkvist, P. Almgren, P. Nilsson, T. Tuomi, B. Isomaa, L. Groop, A. Vaag, et al. 2008. Age influences DNA methylation and gene expression of COX7A1 in human skeletal muscle. Diabetologia. 51: 1159-1168.
17. Ling, C., S. Del Guerra, R. Lupi, T. Ronn, C. Granhall, H. Luthman, P. Masiello, P. Marchetti, L. Groop, and S. Del Prato. 2008. Epigenetic regulation of PPARGC1A in human type 2 diabetic islets and effect on insulin secretion. Diabetologia. 51: 615-622.
18. Folch, J., M. Lees, and G. H. Sloane Stanley. 1957. A simple method for the isolation and purification of total lipides from animal tissues. J. Biol. Chem. 226: 497-509.
19. Cnop, M., J. C. Hannaert, A. Hoorens, D. L. Eizirik, and D. G. Pipeleers. 2001. Inverse relationship between cytotoxicity of free fatty acids in pancreatic islet cells and cellular triglyceride accumulation. Diabetes. 50: 1771-1777.
20. Jiang, M. H., J. Fei, M. S. Lan, Z. P. Lu, M. Liu, W. W. Fan, X. Gao, and D. R. Lu. 2008. Hypermethylation of hepatic Gck promoter in ageing rats contributes to diabetogenic potential. Diabetologia. 51: 1525-1533.
21. Millar, J. S., D. A. Cromley, M. G. McCoy, D. J. Rader, and J. T. Billheimer. 2005. Determining hepatic triglyceride production in mice: comparison of poloxamer 407 with Triton WR-1339. J. Lipid Res. 46: 2023-2028.
22. Raabe, M., M. M. Veniant, M. A. Sullivan, C. H. Zlot, J. Bjorkegren, L. B. Nielsen, J. S. Wong, R. L. Hamilton, and S. G. Young. 1999. Analysis of the role of microsomal triglyceride transfer protein in the liver of tissue-specific knockout mice. J. Clin. Invest. 103: 1287-1298.
23. Miyake, J. H., X. D. Doung, W. Strauss, G. L. Moore, L. W. Castellani, L. K. Curtiss, J. M. Taylor, and R. A. Davis. 2001. Increased production of apolipoprotein B-containing lipoproteins in the absence of hyperlipidemia in transgenic mice expressing cholesterol 7 alpha-hydroxylase. J. Biol. Chem. 276: 23304-23311.
24. Wetterau, J. R., M. C. Lin, and H. Jamil. 1997. Microsomal triglyceride transfer protein. Biochim. Biophys. Acta. 1345: 136-150.
25. Bernard, S., S. Touzet, I. Personne, V. Lapras, P. J. Bondon, F. Berthezene, and P. Moulin. 2000. Association between microsomal triglyceride transfer protein gene polymorphism and the biological features of liver steatosis in patients with type II diabetes. Diabetologia. 43: 995-999. (Pubitemid 30655718)
26. Merriman, R. B., B. E. Aouizerat, and N. M. Bass. 2006. Genetic influences in nonalcoholic fatty liver disease. J. Clin. Gastroenterol. 40 (Suppl 1): S30-S33.
27. Namikawa, C., Z. Shu-Ping, J. R. Vyselaar, Y. Nozaki, Y. Nemoto, M. Ono, N. Akisawa, T. Saibara, M. Hiroi, H. Enzan, et al. 2004. Polymorphisms of microsomal triglyceride transfer protein gene and manganese superoxide dismutase gene in non-alcoholic steatohepatitis. J. Hepatol. 40: 781-786. (Pubitemid 38507358)
28. Gambino, R., M. Cassader, G. Pagano, M. Durazzo, and G. Musso. 2007. Polymorphism in microsomal triglyceride transfer protein: a link between liver disease and atherogenic postprandial lipid profile in NASH? Hepatology. 45: 1097-1107.
29. Stefano, J. T., C. P. de Oliveira, M. L. Correa-Giannella, V. M. de Lima, S. V. de Sa, E. P. de Oliveira, E. S. de Mello, D. Giannella- Neto, V. A. Alves, and F. J. Carrilho. 2007. Nonalcoholic steatohepatitis (NASH) in ob/ob mice treated with yo jyo hen shi ko (YHK): effects on peroxisome proliferator-activated receptors (PPARs) and microsomal triglyceride transfer protein (MTP). Dig. Dis. Sci. 52: 3448-3454.
30. Abidi, P., Y. Zhou, J. D. Jiang, and J. W. Liu. 2005. Extracellular signal-regulated kinase-dependent stabilization of hepatic low-density lipoprotein receptor mRNA by herbal medicine berberine. Arterioscler. Thromb. Vasc. Biol. 25: 2170-2176.
31. Gutierrez-Juarez, R., A. Pocai, C. Mulas, H. Ono, S. Bhanot, B. P. Monia, and L. Rossetti. 2006. Critical role of stearoyl-CoA desaturase- 1 (SCD1) in the onset of diet-induced hepatic insulin resistance. J. Clin. Invest. 116: 1686-1695.
32. Mar-Heyming, R., M. Miyazaki, D. Weissglas-Volkov, N. A. Kolaitis, N. Sadaat, C. Plaisier, P. Pajukanta, R. M. Cantor, T. W. de Bruin, J. M. Ntambi, et al. 2008. Association of stearoyl-CoA desaturase 1 activity with familial combined hyperlipidemia. Arterioscler. Thromb. Vasc. Biol. 28: 1193-1199.
33. Dobrzyn, P., A. Dobrzyn, M. Miyazaki, P. Cohen, E. Asilmaz, D. G. Hardie, J. M. Friedman, and J. M. Ntambi. 2004. Stearoyl-CoA desaturase 1 deficiency increases fatty acid oxidation by activating AMP-activated protein kinase in liver. Proc. Natl. Acad. Sci. USA. 101: 6409-6414.
34. Stefanovic-Racic, M., G. Perdomo, B. S. Mantell, I. J. Sipula, N. F. Brown, and R. M. O'Doherty. 2008. A moderate increase in carnitine palmitoyltransferase 1a activity is sufficient to substantially reduce hepatic triglyceride levels. Am. J. Physiol. Endocrinol. Metab. 294: E969-E977.
35. Hussain, M. M., P. Rava, X. Pan, K. Dai, S. K. Dougan, J. Iqbal, F. Lazare, and I. Khatun. 2008. Microsomal triglyceride transfer protein in plasma and cellular lipid metabolism. Curr. Opin. Lipidol. 19: 277-284.
36. Knutson, S. K., B. J. Chyla, J. M. Amann, S. Bhaskara, S. S. Huppert, and S. W. Hiebert. 2008. Liver-specific deletion of histone deacetylase 3 disrupts metabolic transcriptional networks. EMBO J. 27: 1017-1028.
37. Kuriyama H, S. Yamashita, I. Shimomura, T. Funahashi, M. Ishigami, K. Aragane, K. Miyaoka, T. Nakamura, K. Takemura, Z. Man, et al. 1998. Enhanced expression of hepatic acyl-coenzyme A synthetas and microsomal triglyceride transfer protein messenger RNAs in the obese and hypertriglyceridemic rat with visceral fat accumulation. Hepatology. 27: 557-562.
38. Bennett, A. J., M. A. Billett, A. M. Salter, and D. A. White. 1995. Regulation of hamster hepatic microsomal triglyceride transfer protein mRNA levels by dietary fats. Biochem. Biophys. Res. Commun. 212: 473-478.
39. Quesada, H., J. M. del Bas, D. Pajuelo, S. Diaz, J. Fernandez-Larrea, M. Pinent, L. Arola, M. J. Salvado, and C. Blade. 2009. Grape seed proanthocyanidins correct dyslipidemia associated with a high-fat diet in rats and repress genes controlling lipogenesis and VLDL assembling in liver. Int. J. Obes. 33: 1007-1012.
40. Liang, G., F. A. Gonzales, P. A. Jones, T. F. Orntoft, and T. Thykjaer. 2002. Analysis of gene induction in human fibroblasts and bladder cancer cells exposed to the methylation inhibitor 5-aza-2′-deoxycytidine. Cancer Res. 62: 961-966. (Pubitemid 34160269)
41. Momparler, R. L., and J. Ayoub. 2001. Potential of 5-aza-2′- deoxycytidine (Decitabine) a potent inhibitor of DNA methylation for therapy of advanced non-small cell lung cancer. Lung Cancer. 34: S111-S115.